PRPL Add to watchlist
$0.60 0.02 (-2.89%)
After Hours: $0.60 +0.00 (+0.00%)
Last updated: Apr 15, 2026 21:09
52-Week Range
$0.60
$0.56 $0.60 $1.26

Fundamentals Overview

Purple Innovation, Inc. is near the low of its 52-week range with low valuation, trending downward today.

Valuation low

P/S 0.14

Risk (Beta)

1.84 — higher vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 60% confidence Risk: High Volatility — Beta 1.84. Consider smaller position size due to higher beta.

Supporting (Buy):

Analyst grade: B-

Pressures (Sell):

3M vs S&P 500: -19.6% · 3M vs Consumer Cyclical sector: -13.8% · Beta 1.84 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$65.29M
P/E (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
52-Week Range
$0.56 - $1.26
Volume vs Avg
N/A
Beta
1.84

About

Purple Innovation, Inc. designs and manufactures mattresses, pillows, and cushions. The company also offers bases, foundations, sheets, mattress protectors, bed frames, seat cushions, weighted blankets, and duvets, as well as pet beds. It markets and sells its products through its e-commerce online channels retail brick-and-mortar wholesale partners, and third-party online retailers, as well as through Purple retail showrooms. The company was founded in 2010 and is headquartered in Lehi, Utah.
Sector: Consumer Cyclical
Headquarters: US
Employees: 1,200
IPO Date: Oct 2015
Website: purple.com
Beta: 1.84 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B-. Recent institutional grades: mixed. Current institutional positions: Buy: 4, Hold: 3, Neutral: 6, Outperform: 10, Overweight: 6, Perform: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $-4.06; current price is $0.60. That’s a -775.5% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) N/A
PEG (TTM) N/A
P/B (TTM) N/A
P/S (TTM) 0.14
Liquidity & enterprise
Current Ratio (TTM) 1.35
Quick Ratio (TTM) 0.76
Cash Ratio (TTM) 0.24
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) -10.97%
Gross margin (TTM) 40.23%
Operating margin (TTM) -9.18%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for PRPL.

Analyst Sentiment at a Glance

B- Sentiment Mixed
Buy 4Hold 3Neutral 6Outperform 10Overweight 6Perform 1
3 upgrades, 3 downgrades
Price Target Consensus
Current $0.60
Median $1.50
Consensus $2.87
Low consensus $1.10
High consensus $6.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
UBS maintain Neutral Neutral 2026-04-01
Wedbush maintain Neutral Neutral 2025-03-26
Wedbush downgrade Outperform Neutral 2024-09-04
Craig-Hallum maintain Hold Hold 2024-08-06
Wedbush maintain Outperform Outperform 2024-05-08
Roth MKM maintain Buy Buy 2024-03-21
Craig-Hallum maintain Hold Hold 2024-03-13
Roth MKM upgrade Neutral Buy 2024-03-13
Wedbush maintain Outperform Outperform 2024-03-13
Roth MKM maintain Neutral Neutral 2024-03-07
Wedbush maintain Outperform Outperform 2024-01-24
Keybanc maintain Overweight Overweight 2024-01-24
Oppenheimer downgrade Outperform Perform 2023-11-13
Wedbush maintain Outperform Outperform 2023-11-10
Craig-Hallum downgrade Buy Hold 2023-11-10
Keybanc maintain Overweight Overweight 2023-11-10
Oppenheimer maintain Outperform Outperform 2023-08-25
Oppenheimer maintain Outperform Outperform 2023-08-24
Wedbush maintain Outperform Outperform 2023-08-10
Wedbush maintain Outperform Outperform 2023-08-09
Wedbush maintain Outperform Outperform 2023-04-14
UBS maintain Neutral Neutral 2023-03-21
UBS maintain Neutral Neutral 2023-03-20
Keybanc maintain Overweight Overweight 2023-02-01
Keybanc maintain Overweight Overweight 2023-01-31
Keybanc maintain Overweight Overweight 2023-01-12
Keybanc maintain Overweight Overweight 2023-01-11
Craig-Hallum upgrade Hold Buy 2022-11-10
Craig-Hallum upgrade Hold Buy 2022-11-09
Wedbush maintain Outperform Outperform 2022-09-20